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Background/aim: Filaggrin is a protein complex involved in epidermal differentiation and skin barrier formation. Mutations of the
filaggrin gene (FLG) are associated with allergen sensitization and allergic diseases like atopic dermatitis (AD), allergic rhinitis, food
allergy (FA), and asthma. The aim of the study is to reveal the frequency of change in the FLG gene and determine the association
between FLG loss-of-function (LOF) mutations and FA and/or AD in Turkish children.
Materials and methods: Four FLG loss-of-function (LOF) mutations known to be common in European populations were analyzed
in 128 healthy children, 405 food-allergic children with or without atopic dermatitis, and 61 children with atopic dermatitis. PCRRFLP was performed for genotyping R501X, 2282del4, and R2447X mutations; S3247X was genotyped using a TaqMan-based allelic
discrimination assay. Results were confirmed by DNA sequence analysis in 50 randomly chosen patients for all mutations.
Results: A total of 466 patients [(67% male, 1 (0.7–2.8) years] and 128 healthy controls [59% male, 2.4 (1.4–3.5) years)] were included
in this study. Two patients were heterozygous carriers of wild-type R501X, but none of the controls carried this mutation. Three patients
and one healthy control were heterozygous carriers of wild-type 2282del4. Neither patients nor controls carried R2447X or S3247X FLG
mutations. There were no combined mutations determined in heterozygous mutation carriers.
Conclusions: Although R501X, 2282del4, R2447X, and S3247X mutations are very common in European populations, we found that
FLG mutations were infrequent and there is no significant association with food allergy and/or atopic dermatitis in Turkish individuals.
Key words: Atopic dermatitis, filaggrin, food allergy, R501X, 2282del4, R2447X, S3247X

1. Introduction
Filaggrin (FLG) is a protein complex involved in epidermal
differentiation and skin barrier formation [1]. Filaggrin
is first synthesized as profilaggrin in the keratohyalin
granules of the stratum granulosum [2]. During the
terminal differentiation of keratinocytes, profilaggrin is
activated by dephosphorylation and proteolytic cleavage.
Then, FLG monomers aggregate in the keratin filament
as tight bundles causing the collapse of the keratinocytes,
which become flattened and tightly packed and form
the stratum corneum (SC) [1,2]. Filaggrin monomers in
the SC are deiminated and degraded into amino acids
including histidine, arginine, and glutamine which are then
hydrolyzed to form natural moisturizing factors (NMFs)
which mainly contribute to epithelial hydration and the

barrier function of the SC [3]. In addition to the moisture
retention function of NMFs, they perform functions
essential to acidic pH maintenance and inhibition of
pathogenic bacteria [3,4].
Previous studies have shown that loss-of-function
(LOF) mutations in the FLG gene are associated with
allergic diseases such as atopic dermatitis (AD), allergic
rhinitis, food allergy (FA), and asthma [5]. Filaggrin
mutation has been identified as an important risk
factor, particularly for the development of AD, and LOF
mutations in FLG are found in 16%–44% of European
patients with moderate to severe AD [4]. The spectrum of
mutations in FLG show a population-specific distribution
profile among Asian, African American, and Northern
and Southern European patients [6]. Although over 40
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LOF mutations of FLG were determined in European and
Asian populations to date, a limited number of them, such
as R501X, 2282del4, R2447X, and S3247X mutations, are
common in European Caucasians [1,4,6].
In a mouse model a 1-base pair deletion mutation
in FLG, which is analogous to common human FLG
mutations, predisposed antigen transfer through a
defective epidermal barrier and resulted in elevated food
allergen IgE sensitization [7]. Thereafter, the association
of sensitization to food allergens, such as hen’s egg, cow’s
milk, and peanut, with LOF mutations in the FLG gene
has been investigated in many clinical studies, and these
studies exhibit some contradictory results [7–9]. Filaggrin
mutations increased the risk of food sensitization in the
first year of life but did not play a further role in progression
from asymptomatic egg and peanut sensitization to FA [8].
In other studies, having FLG-LOF mutations was strongly
associated with clinical FA [10,11].
The aim of this study was to determine the frequency of
the most common LOF mutations in a Turkish population
and to investigate the association of FLG-LOF mutations
with FA and AD.
2. Materials and methods
2.1. Study participants
Patients who were referred to Hacettepe University,
Division of Pediatric Allergy and diagnosed with IgEmediated FA (hen’s egg, cow’s milk, tree nuts, peanut,
wheat, legumes, beef, etc.) with or without AD and
patients who were referred due to AD without a history
of FA between January 2009 and May 2013 were included
in the study. The serum total and specific IgE levels were
measured with the ImmunoCAP system in accordance
with manufacturer instructions (Thermo Fisher Scientific,
Uppsala, Sweden). Eosinophil counts were identified using
the Coulter Counter (Beckman Coulter, California, USA)
[12]. IgE-mediated FA diagnosis was based on the presence
of a consistent clear-cut history of allergic symptoms that
occurred after the ingestion of a specific food together with
the presence of either elevated titers of serum specific IgE
(>0.35 kU/L) or a positive skin-prick test for the respective
food allergen [13]. The diagnosis of AD was based on the
presence of chronic pruritus and eczematous dermatitis
with typical age-specific morphology, distribution pattern,
and a chronic relapsing course [14]. The severity of AD
was determined by SCORing atopic dermatitis index
(SCORAD) and graded as severe or nonsevere (mild to
moderate) AD [15]. Inclusion criteria for patients were
a diagnosis of either IgE-mediated FA and/or AD based
on the abovementioned criteria. The exclusion criteria
include being diagnosed with a chronic systemic illness
apart from allergic diseases, such as chronic respiratory,
cardiac, gastroenterological, neurologic, or genetic
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diseases. Patients were divided into three groups: patients
with FA and with AD (FA w AD), solely FA without AD
(FA w/o AD), and AD without FA (AD w/o FA).
The patients were compared according to demographic
and clinical features as well as their baseline eosinophil
counts and total IgE values. Diagnoses of asthma and
allergic rhinitis were based on guidelines [16,17].
Age- and sex-matched healthy controls constituted the
control group of study participants. They were recruited
from patients who applied to the general pediatrics
outpatient clinics of the hospital due to a nonallergic
complaint and who were not there for follow-up due to
a systemic, chronic illness. The past medical history of
healthy controls was taken by questionnaire and given
to all control participants and their families to screen for
and exclude the presence of any allergic disease, including
allergic rhinitis, atopic dermatitis, asthma, food allergy,
chronic urticaria, and venom hypersensitivity. Four
common FLG-LOF mutations in European populations
(R501X, 2282del4, R2447X, and S3247) were screened
for by PCR-RFLP and the TaqMan genotyping method.
Results were confirmed by DNA sequence analysis in 50
randomly chosen patients for all mutations.
2.2. Genotyping of filaggrin gene mutations
Genomic DNA was extracted from whole blood samples
using the modified methods of Poncz et al. [18]. Four
common FLG-LOF mutations in European populations
(R501X, 2282del4, R2447X, and S3247) were screened
for by PCR-RFLP and TaqMan genotyping method
[19,20]. PCR-RFLP was performed for genotyping R501X,
2282del4, and R2447X mutations; S3247X was genotyped
by TaqMan-based allelic discrimination assay (Applied
Biosystems, Foster City, CA, USA). PCR primers and wild
and mutant probe sequences are listed in Table 1.
The amplicon was digested with Hin1II (Thermo Fisher
Scientific, Waltham, MA, USA) for R501X, AdeI (Thermo
Fisher Scientific Waltham, MA, USA) for 2282del4, and
BssSI (NEB, Ipswich, MA, USA) for R2447X. The digested
PCR fragments were run on 2% agarose gel. The S3247X
mutations were screened using ABI 7500 (96-well) Fast
Real-Time PCR systems. Fifty samples were randomly
selected and sequenced for confirmation of the genotyping
results. The sequencing reaction was performed by Big
Dye Terminator cycle sequencing kit (version 3.2) using
the ABI Prism 310 sequence detection system (Foster City,
CA, USA).
2.3. Statistical analysis
SPSS 21.0 software (SPSS Inc., Chicago, IL, USA) was used
for data analysis. Frequencies and percentages were used
to describe categorical variables, and the comparisons of
variables between groups were performed by chi-square
test. The numerical variables were described as median
(interquartile range) due to nonnormal distribution,
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comparisons between the groups in regard to numerical
variables were obtained by Kruskal–Wallis test, and
comparisons for categorical variables were established
via χ2 test. A P-value <0.05 was considered statistically
significant.
3. Results
Four hundred and sixty-six patients [67% male, 1 (0.7–2.8)
years] and 128 healthy controls [59% male, 2.4 (1.4–3.5)

years)] were included in this study. Only 2% of patients
with AD were classified as having severe AD. One hundred
and thirty-two patients (28%) had IgE-mediated FA
without AD, 273 (59%) had FA and AD, and 61 (13%)
had AD without FA. The age of onset for AD did not
differ between patients with and without FA (p > 0.05),
but the age of participants was different between groups
(p < 0.001). The characteristic features of the patients and
healthy controls are presented in Table 2.

Table 1. Primers and probes for genotyping of the FLG mutations.
Forward 5’-CACGGAAAGGCTGGGCTG-3’

R501

Reverse 5’-ACCTGAGTGTCCAGACCTATT-3’
Forward 5’-ATTAGGTCTGGACACTCAGGT-3’

2282del4

Reverse 5’-GGGAGGACTCAGACTGTTT-3’
Forward 5’-CCACACGTGGCCGGTCAGCA- 3’

R2447X

Reverse 5’-GTCCTGACCCTCTTGGGACGT-3’
Forward 5’-TGAAGCTTCCACTCATGCCG-3’

S3247X (for sequencing)

Reverse 5’-ATGAAGCTTGTCCACGCGGA-3’
Forward 5’- CCAGAAACCATCGTGGATCTG-3’

S3247X (for Taqman genotyping)

Reverse 5’-TGCCTGATTGTCTGGAGCG- 3’
Wild type: FAM 5’-CAGTCAAGGCACGG-3’ MGB/BHQ
Mutant: VIC 5’-AGCAGTAAAGGCACG-3’ MGB/BHQ

Table 2. Demographic and clinical features of the study participants.
Allergic Disease

Healthy
Controls
n = 128

P*

2.0 (0.8–4.8)

2.4 (1.4–3.5)

<0.001 <0.001

Food Allergy
n = 132

Food Allergy &
Atopic Dermatitis
n = 273

Atopic
Dermatitis
n = 61

Current Age‡ (years)

2 (1-5.5)

1.0 (0.6––1.6)

P†

Sex (male) n, (%)

86 (65.2)

191 (70.0)

37 (60.7)

75 (58.6)

NS

Age of onset of AD‡(years)

–

0.3 (0.2–0.5)

0.3 (0.1–1.6)

-

<0.001 –

Eosinophil (%)‡

3.8 (2.3–7.2)

5.9 (3.3–9.1)

4.7 (3.0–7.3)

1.8 (1.2–3.0)

<0.001 <0.001

Eosinophil number (/µL)

400 (200–700)

600 (327.5–1083.2) 400 (200–700) 193 (100–300) <0.001 <0.001

Total IgE‡ (kU/L)

94.8 (40.5–271.3) 86.0 (32.3–272.8)

40.2 (8.5–188) 12.7 (5.0–38)

0.002

Asthma, n (%)

62 (47.7)

70 (25.6)

7 (11.9)

-

<0.001 -

Allergic rhinitis, n (%)

27 (20.6)

29 (10.6)

10 (16.9)

-

0.022

-

Family hx of atopic disease, n (%)

43 (34.4)

110 (40.6)

24 (41.4)

21 (20)

NS

0.002

Cow’s milk allergy, n (%)

79 (60.8)

159 (59.1)

-

-

NS

-

Hen’s egg allergy, n (%)

53 (41.1)

230 (84.9)

-

-

<0.001 -

Tree nuts-peanut allergy, n (%)

36 (28.3)

85 (31.6)

-

-

NS

Multiple food allergy, n (%)

54 (41.5)

167 (61.6)

-

-

<0.001 -

Anaphylaxis in the hx or during OFC test

74 (56.1)

72 (26.4)

-

-

<0.001 -

‡

NS

<0.001

-

P: Comparison between the patients with allergic disease †P: comparison of the four groups of patients with and without allergic disease.
Median (interquartile range) OFC: Oral Food Challenge NS: Non significant p > 0.05.

*

‡
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According to genotyping results, two patients from
FA group were heterozygous carriers of R501X, although
none of the controls carried this mutation (Table 3). Three
patients in the FA with AD group and one of the healthy
children were heterozygous carriers of wild-type 2282del4.
Neither patients nor controls carried the other two FLG
mutations, R2447X and S3247X. We could not determine
any combined mutation in the heterozygous mutation
carriers. Table 3 shows the genetic analysis summary for
study participants. Clinical features of the heterozygous
carriers are given in Table 4.
Although R501X, 2282del4, R2447X, and S3247X
mutations are very common in European populations,
according to our results, these FLG mutations are rarely
found in Turkish individuals. Due to the low frequency
of these mutations, no associations were shown between
these mutations and FA and/or AD.
4. Discussion
In this study we revealed that the frequency of four
common FLG LOF mutations was low or absent in a
Turkish population and that these mutations were not a risk
factor for FA and/or AD development in this population,
although R501X, 2282del4, R2447X, and S3247X
mutations are very common in European populations.

LOF mutations in the FLG gene are a major risk factor
for allergic diseases such as AD, FA, allergic rhinitis, and
asthma and are generally associated with the natural
development of atopic march [5,21]. The association of
changes in FLG with the abovementioned diseases was
initially described in patients with ichthyosis vulgaris by
Smith et al. in 2006 [20]. In that study, LOF mutations
of R501X and 2282del4 were significantly associated
with ichthyosis vulgaris in Irish, Scottish, and European
American families [20].
In the years since, many population studies have been
performed showing the importance of FLG mutations in
atopic diseases, and population-specific LOF mutations
have been confirmed by many studies [1,6,20,22].
According to these studies, 49 truncating mutations in
the FLG gene have been identified as European-specific
and Asian-specific mutations [23]. The most common
mutations, R501X, 2282del4, R2447X, and S3247X
existed with a frequency of 7%–10% in a white European
population [22].
Population studies to date have primarily focused on
the relationship between FLG mutations and AD; the
relevance of atopic sensitization, allergic rhinitis, and
asthma on FLG mutations has also been investigated
[5]. Studies have shown that mutations of R501X and/or

Table 3. Summary of the genetic analysis of the study participants.
Methods used

Food allergy

Food allergy +
Atopic dermatitis

Atopic dermatitis

Healthy controls

R501X

PCR-RFLP n = 588
DNA sequencing n =38

Wild n = 129
Heterozygous n =2

Wild n = 268
Heterozygous : -

Wild n = 61
Heterozygous : -

Wild n = 128
Heterozygous : -

2282del4

PCR-RFLP n = 582
DNA sequencing n = 20

Wild n = 130
Heterozygous : -

Wild n = 268
Heterozygous n = 3

Wild n = 61
Heterozygous : -

Wild n = 119
Heterozygous n:1

R2447X

PCR-RFLP n = 588
DNA sequencing n = 32

Wild n = 129
Heterozygous : -

Wild n = 272
Heterozygous : -

Wild n = 61
Heterozygous : -

Wild n = 123
Heterozygous : -

S3247X

RT-PCR n = 522
DNA sequencing n = 81

Wild n = 131
Heterozygous : -

Wild n = 269
Heterozygous : -

Wild n = 54
Heterozygous : -

Wild n = 117
Heterozygous : -

Table 4. Features of the patients with FA and/or AD with heterozygous mutations for frequently encountered variants of filaggrin gene.
Patient No Polymorphism

Sex

Age
(year)

Type of food allergy

Concurrent
AD

Aeroallergen
sensitization

Asthma

Food induced
Anaphylaxis

1

R501X

Male

16

CM, hazelnut

-

Grass pollen

+

-

2

R501X

Female

2.4

Hazelnut

-

-

-

+

3

2282del4

Male

1

Hen’s egg

+

-

+

-

4

2282del4

Male

1

Hen’s egg

+

-

-

-

5

2282del4

Male

0.8

Hen’s egg, hazelnut

+

-

-

-
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2282del4 and, to a lesser extent, R2447X and/or S3247X
were associated with early-onset AD [1,3,6,19].
The association between FLG-LOF mutations and
asthma has been determined in many studies [24–26].
Although FLG-LOF mutations were an independent risk
factor for asthma development in some studies, these
mutations have a higher impact as risk factors for asthma
development among AD patients [25,27–29]. The risk of
developing asthma increased more than 2.5-fold (OR,
2.64; 95% CI, 1.76–4.00) in school children with AD
compared to those without AD [26]. In addition, these
LOF mutations in FLG were identified as risk factors for FA
and concurrent AD with a progression into asthma [9,22].
However, contradictory results have been shown in studies
investigating the function of FLG mutations in FA. Studies
regarding FLG mutations and various allergens have
supported the association of food sensitization and allergy,
including peanut, egg, and cow’s milk, with FLG mutations.
Brown et al. showed an association between peanut allergy
and FLG-LOF mutations in children and adult patients
from three different populations. Statistical significance was
also obtained in the case of peanut allergy coexisting with
AD [11]. In a birth cohort study, the association of peanut
allergy with FLG mutations was found in children; a FLGLOF mutation carrier had an increased risk for developing
peanut sensitization and allergy when exposed to peanut
in the first year of life [30]. FLG-LOF mutations were
associated with food allergy and food allergen sensitization
as determined by an allergen panel including egg, milk, soya,
wheat, cod, and peanut [9]. Meanwhile, these significant
results were usually obtained if the studied population had
an AD background [9,10]. In contrast with these studies,
LOF mutations were not associated with egg sensitization
and egg allergy in the Melbourne cohort or with peanut
sensitization and cow’s milk allergy in some other studies
[8,31].
The most common FLG mutations (R501X and
2282del4) and the less common mutations in European
populations (R2447X and S3247X) were rarely detected or
not detected in Asian populations, and different mutations
have been described for these populations. Asian-specific
FLG mutations increase AD and AD with concurrent FA,
but there was no association with asthma [32]. In Croatian
patients with allergic diseases including atopic dermatitis,
allergic rhinitis, asthma, and allergic contact dermatitis,
low frequencies of FLG null mutations (R501X, 2282del4,
R2447X, and S3247X) were detected; however, this study
showed an association of FLG null mutations with other
skin disorders [33].
Although R501X and 2282del4 FLG mutations are
common in Europe, surprisingly, the studies including
Italian populations revealed no significant association
with AD. In these studies, three new specific mutations

were identified by sequence analysis; however, these new
variants were not associated with AD [34]. Paralleling the
Italian study, a study including Egyptian patients showed no
association of R501X and 2282del4 mutations with AD [35].
To our knowledge, the association between LOF mutations
and AD in a Turkish population was investigated in only
one prior study, and no association was found between the
R501X mutation and Turkish children with AD [36].
The prevalence of AD varies greatly worldwide, by
population, and it ranges from 0.9% to 20%. The prevalence
of severe AD is much lower and is estimated at 1%–2% [37].
In the current study the AD group consisted of patients
with mostly mild and moderate AD, and the ratio of severe
AD was 2%. Because the study groups included few patients
with severe AD, it may have been possible to obtain a higher
frequency of LOF mutations, especially among severe AD
groups.
The difference between the ages of patients and healthy
controls may be a limitation of this study, but the frequency
of LOF mutations was very low in both groups and there
were no homozygous mutations in any of the participants.
Additionally, although the onset of allergy and asthma
symptoms may be related to the age of the patient, the
frequency of LOF mutations in DNA cannot change over
time. The method of food allergy diagnosis may also be
a limitation of this study, as the gold standard is an oral
food challenge test [38]. However, a consistent clear-cut
history of allergic symptoms occurring after ingestion of a
specific culprit food together with the presence of specific
IgE has been one of the preferred methods for food allergy
diagnosis in patients in certain respected publications [39].
Additionally, it is obvious that a clear-cut history with the
culprit food together with specific IgE certainly increases the
likelihood of an accurate diagnosis of FA, when compared
to either self-reported history or food-specific IgE alone
[38]. In conclusion, the results of this study show that
FLG mutations particularly R501X, 2282del4, R2447X,
and S3247X do not confer a risk for the development of
FA and/or AD in a Turkish population. In addition to
environmental factors and the influence of differential
exposure to UV, a population-specific genetic background
may be important when considering the association
between FLG mutations and allergic diseases. Different
FLG mutations, diversity in frequency, and varying
relationships with allergic diseases among populations
may express the influence of differential exposure to UV,
with respect to geographic location. However, further
studies are needed.
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